Our Vision for the Future.

We are investing in robust science to determine the extent to which we can control our health & performance. Much of what we think is outside of our control is actually within our control if we have the knowledge. At Epigenix our programs are designed to discover, validate and inform impactful outcomes.


At Epigenix Foundation we have spent $6 million of our own money in 2 years, with no economic end game, to prove the following hypothesis: can cancer be prevented or reversed with a nutritional performance based protocol? Essentially, we are in the validation game.


So, the question we are faced with – do we want an additional 40 years of genetic research with little outcome or, do we ANNIHILATE CANCER TODAY by investing in epigenetics that will provide impactful outcomes?  The Choice is Ours!



Epigenix Foundation promotes research to prevent or ameliorate disease, maximize quality of life and/or improve personal performance. Our research is impacting all the following areas:

  • Cancer
  • Cognitive Function
  • Seizures
  • Physical Performance
  • Diabetes
  • Cardiovascular disease
  • Metabolism



At Ketopet we have been providing human grade cancer therapy for Shelter Dogs with Cancer – This isn’t your typical canine rescue facility. Ketopet goes out of its way to rescue dogs that face euthanization with incurable, terminal cancer. Our goal isn’t to provide hospice-like treatment for terminal dogs – of course we care for and love the animals, but instead of writing off the canine companions to their fate, we at Ketopet provide groundbreaking cancer therapy. We’ve been doing this since October of 2014 and the results are astounding. Plus, we guarantee each dog will have a loving forever home, for life.



Our focus is on early detection. We evaluate the latest diagnostic tools and test their efficacy for use in our early intervention protocols.

The ONCOblot® Test is being used to confirm cancer presence. The test provides a non-invasive next step to existing tests such as a High PSA, Abnormal Mammogram, Suspicious PET Scan and biopsies. The test is being used to identify cancers where the primary site is unknown, for recurrence monitoring, post cancer treatments and for targeted high risk populations. ONCOblot® is the future of pre-cancer screening. Combined with our ketogenic nutritional protocol it is providing a solid one-two punch to crushing cancer.

Currently The ONCOblot® Test can detect 27 different types of cancer in humans – we are working to develop this level of testing for dogs and on improving the current test so that it becomes the mainstay of early stage cancer detection at an affordable price.


Conference on Nutritional Ketosis and Metabolic Therapeutics 

Scientific conference held by Epigenix Foundation, Dominic D’Agostino and the USF team, February 1st-4th in Tampa, Florida. The event will bring together a range of international experts who will speak about the science and application of nutritional and metabolic therapies for the treatment and prevention of cancer, neurological diseases, and metabolic disorders, as well as for optimizing wellness and human performance. To purchase tickets or learn more go to: www.metabolictherapeutics.com or RSVP here.

Facebook By Weblizar Powered By Weblizar